Total Return chart PharmaEssentia Corporation LUXEMBOURG S.E.

Stocks

End-of-day quote LUXEMBOURG S.E. 2026-10-16			5-day change	1st Jan Change
38.40 ^USD	+3.23%		+2.67%	+184.16%

09-18	PharmaEssentia Gets Experts Board's Recommendation to Continue Phase 3 Myelofibrosis Drug Trial	MT
09-02	PharmaEssentia Receives FDA Approval For Ropeginterferon Alfa-2b-njft For Essential Thrombocythemia	CI

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.

2026-07-08	Annual 1.490152 TWD
2025-08-10	Annual 1.098385 TWD